Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 15/20 | 0.58 |
| ▸ | TDP2 | O95551 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6191569 | 0.85 | ADORA1 (0.50) | ADORA1TDP2LMNATP53MAPT | |
| Hydrochloric Acid SCHEMBL7895436 | 0.84 | ADORA1 (0.49) | ADORA1TDP2LMNATP53MAPT | |
| Iodide SCHEMBL3994778 | 0.73 | ADORA1 (0.84) | ADORA1 | |
| SCHEMBL12798139 | 0.73 | CHEK1 (0.65) | ADORA1TP53MAPT | |
| SCHEMBL2091654 | 0.71 | KDM1A (0.48) | ADORA1 | |
| SCHEMBL6190822 | 0.70 | ADORA1 (0.49) | ADORA1TDP2MAPT | |
| Iodide SCHEMBL3990143 | 0.69 | ADORA1 (0.78) | ADORA1 | |
| SCHEMBL2091651 | 0.69 | PTGS1 (0.47) | ADORA1 | |
| SCHEMBL11964988 | 0.69 | ADORA2A (0.48) | ADORA1 | |
| Bromide SCHEMBL7903347 | 0.68 | ADORA1 (0.48) | ADORA1TDP2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1183247-B1 | POLYCYCLIC THIAZOLE SYSTEMS AND THEIR UTILIZATION AS ANORECTICS | AVENTIS PHARMA GMBH (DE) | 2005-05-25 | — | — | EP | disclosed |
| EP-1156805-B1 | USE OF POLYCYCLIC THIAZOLE SYSTEMS FOR MANUFACTURING MEDICAMENTS FOR PREVENTING OR TREATING OBESITY | AVENTIS PHARMA GMBH (DE) | 2004-08-11 | — | — | EP | disclosed |
| EP-1183247-A1 | POLYCYCLIC THIAZOLE SYSTEMS AND THEIR UTILIZATION AS ANORECTICS | Aventis Pharma Deutschland GmbH (DE) | 2002-03-06 | — | — | EP | disclosed |
| US-6329407-B1 | ANOREXOGENIC AGENTS | AVENTISPHARMA DEUTSCHLAND GMBH (DE) | 2001-12-11 | — | — | US | disclosed |
| EP-1156805-A2 | USE OF POLYCYCLIC THIAZOLE SYSTEMS FOR PRODUCING MEDICAMENTS FOR PREVENTING OR TREATING OBESITY | Aventis Pharma Deutschland GmbH (DE) | 2001-11-28 | — | — | EP | disclosed |
| US-6187801-B1 | 6-CHLORO-2-METHYL-8H-INDENO(1,2-D)-THIAZOLE HYDROCHLORIDE, FOR EXAMPLE; ADMINISTERING TO TREAT OBESITY, DIABETES; ANORECTICS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-02-13 | — | — | US | disclosed |
| WO-2000051579-A2 | USE OF POLYCYCLIC THIAZOLE SYSTEMS FOR PRODUCING MEDICAMENTS FOR PREVENTING OR TREATING OBESITY | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-09-08 | — | — | WO | disclosed |
| WO-2000051997-A1 | POLYCYCLIC THIAZOLE SYSTEMS AND THEIR UTILIZATION AS ANORECTICS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-09-08 | — | — | WO | disclosed |